Author: Rachel Paul

Rachel Paul is a Senior Medical Content Specialist. She has a Masters Degree in Pharmacy from Osmania University. She always has a keen interest in medical and health sciences. She expertly communicates and crafts latest informative and engaging medical and healthcare narratives with precision and clarity. She is proficient in researching, writing, editing, and proofreading medical content and blogs.

tachycardia
Unlocking Tachycardia Mysteries: Stem Cell Heart Tissue Model Breakthrough

Heart rates are now easier to track than ever before. Because smartwatches can detect a.

antimicrobial resistance
AI Blueprint for Global Antimicrobial Resistance

Researchers at the University of Liverpool have developed a framework for artificial intelligence (AI) to.

Anaphylaxis
New Anaphylaxis & Atopic Dermatitis Guidelines

The Joint Task Force for Practice Parameters (JTFPP) has released two new practice parameters that.

behavioral issues
Sleep Disturbances Linked to Preschool Behavioral Issues

Previous research has indicated that both childhood behavioral difficulties and poor mental health are strongly.

Noma
WHO Recognizes Noma as Neglected Tropical Disease

The World Health Organization (WHO) today announced the addition of noma (cancrum oris or gangrenous.

Syphilis
The rising health crisis of congenital Syphilis

Congenital syphilis, a disease transmitted to babies during pregnancy, is on the rise globally, with.

nausea
GDF15 and Pregnancy Nausea

Researchers investigated the potential association of growth/differentiation factor 15 (GDF15), a fetal hormone, with nausea.

NREM sleep
Stress Induced Neuronal Activation – Impact on Sleep

According to new research, neurons in the preoptic hypothalamus—the part of the brain that regulates.

infants
Exploring Infants Communication Across Six Continents

Elika Bergelson, an associate professor of psychology at Harvard, researches how newborns and infants learn.

covid vaccine
Robust Boosting Potential of Two COVID-19 Vaccines

According to the interim results of a Phase 1 clinical trial, two Melbourne-made COVID-19 vaccines.